LUND, Sweden--(BUSINESS WIRE)--Regulatory News:
BioInvent (STO:BINV)
The rights issue in BioInvent of MSEK 77.7, with preferential rights for the company’s shareholders, has been oversubscribed.The subscription period ended on 13 May 2015. Approx. 96 per cent of the shares offered have been subscribed for with subscription rights and 4.2 per cent of the shares offered have been allocated to persons who subscribed for shares without subscription rights. In total, notifications to subscribe for shares without subscriptions rights have been received corresponding to 30 per cent of the shares offered. Hence, the rights issue guarantee undertakings have not been made use of.
Help employers find you! Check out all the jobs and post your resume.
